Lens culinaris-agglutinin-reactive fraction of alpha-fetoprotein is a prognostic biomarker in atezolizumab plus bevacizumab for hepatocellular carcinoma
AFP-L3 is a useful biomarker for predicting the response and prognosis of patients with ATZ/BV for u-HCC. AFP-L3 should be measured together with AFP and DCP levels.
Authors
- Jumpei Okamura (ORCID: https://orcid.org/0000-0002-3312-4128)
- Hideyuki Tamai (ORCID: https://orcid.org/0000-0003-4511-4573)
Institutions
- Wakayama Rosai Hospital (JP)
Publication Details
- Journal
- European Journal of Gastroenterology & Hepatology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1097/meg.0000000000002979
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00